Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailNarrative Songs of the Bruges Lacemakers (1730-1879)
Peere, Isabelle ULg

Conference (2007, September)

A general account of the textual and contextual data on lacemakers' songs provided by Lootens and Feys' song collection, Chants populaires flamands (1879) as a valuable source of information on the ... [more ▼]

A general account of the textual and contextual data on lacemakers' songs provided by Lootens and Feys' song collection, Chants populaires flamands (1879) as a valuable source of information on the complex study of the lacemaking tradition [less ▲]

Detailed reference viewed: 74 (1 ULg)
Full Text
Peer Reviewed
See detailDie Narrenburg im Waldwinkel. Theodor Storms Auseinandersetzung mit Adalbert Stifter
Leyh, Valérie ULg

in Sprachkunst. Beiträge zur Literaturwissenschaft (2011), 42

Comme l'ont déjà évoqué plusieurs chercheurs, la nouvelle "Waldwinkel" (1874) de Theodor Storm montre de nombreuses correspondances avec le récit "Die Narrenburg" (1842) d'Adalbert Stifter. Or jusqu'à ... [more ▼]

Comme l'ont déjà évoqué plusieurs chercheurs, la nouvelle "Waldwinkel" (1874) de Theodor Storm montre de nombreuses correspondances avec le récit "Die Narrenburg" (1842) d'Adalbert Stifter. Or jusqu'à présent, ce rapport étroit entre ces deux textes narratifs n'a pas encore été étudié en profondeur. Cet article vise dès lors à analyser les continuités et discontinuités entre ces deux récits. Une étude minutieuse des stratégies narratives ainsi qu'une analyse comparative des personnages principaux permettent de constater que la nouvelle de Storm fait, certes, renaître le monde de Stifter, mais pour le faire apparaître comme un non-lieu, une utopie. La noblesse, qui chez Stifter parvient encore à se renouveler en s'alliant à la bourgeoisie, est ainsi, chez Storm, vouée au déclin. Le monde représenté dans "Waldwinkel" est, quant à lui, marqué par la réalité du capitalisme et du combat de tous contre tous. [less ▲]

Detailed reference viewed: 48 (9 ULg)
See detailNarrer le ‘dagong’: identification, hégémonie et légitimations de transition
Florence, Eric ULg

Scientific conference (2010, April 27)

Detailed reference viewed: 4 (0 ULg)
Full Text
Peer Reviewed
See detailNarrow band-width wavelength filter by guided mode resonance
Lenaerts, Cedric ULg; Moreau, Vincent; Renotte, Yvon ULg et al

in Optical Engineering : The Journal of the Society of Photo-Optical Instrumentation Engineers (2004), 43(11), 2631-2639

Simple resonant structures that permit holographic reflection filtering are studied. The filters under study work under a 45-deg incidence for a wavelength of λ=632.8 nm, a condition useful for future ... [more ▼]

Simple resonant structures that permit holographic reflection filtering are studied. The filters under study work under a 45-deg incidence for a wavelength of λ=632.8 nm, a condition useful for future inclusion in substrate mode systems. First, the influence of the structural parameters of the grating and the waveguide on the position and the shape of the resonance peaks are studied by numerical computation. The numerical results, obtained within the rigorous coupled wave theory, are compared with the measured response of some filters. These filters contain a grating recorded by holography deposited on the substrate. In the case of the bilayer filter, a waveguide is introduced between the grating and the substrate. Second, the numerical results are used for the conception of an active substrate mode spectral filter built from electro-optic zinc oxide. [less ▲]

Detailed reference viewed: 49 (6 ULg)
See detailNarrow-band photometry of Comet P/Giacobini-Zinner at the time of ICE encounter
Sterken, C.; Manfroid, Jean ULg

in Diversity and Similarity of Comets (1987, September 01)

Narrowband multidiaphragm photometry of comet Giacobini-Zinner, obtained shortly after ICE passed behind the comet's nucleus is summarized. Derived fluxes are presented, and Haser model production rates ... [more ▼]

Narrowband multidiaphragm photometry of comet Giacobini-Zinner, obtained shortly after ICE passed behind the comet's nucleus is summarized. Derived fluxes are presented, and Haser model production rates are given for each night data. The comet appears to be an exception to the production rate-heliocentric distance relation. [less ▲]

Detailed reference viewed: 8 (1 ULg)
Full Text
See detailNarrow-band photometry of the eclipsing WN7+O binary WR 22
Royer, P.; Rauw, Grégor ULg; Manfroid, Jean ULg et al

in Wolf-Rayet Phenomena in Massive Stars and Starburst Galaxies (1999)

In the present paper, we discuss photometric observations of the February 1996 eclipse of the very massive WR+O binary WR 22. Our data were obtained with a set of narrow-band filters, specially designed ... [more ▼]

In the present paper, we discuss photometric observations of the February 1996 eclipse of the very massive WR+O binary WR 22. Our data were obtained with a set of narrow-band filters, specially designed for the study of WR stars. [less ▲]

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailNarrowband versus broadband for tele-education : a critical evaluation
Van Tomme, Emmanuel; Van Droogenbroeck, Marc ULg; Debie, Peter

in International Conference on Technology Supported Learning, Proceedings (1996, November)

Detailed reference viewed: 27 (6 ULg)
See detailNasal aspergillosis in dogs
Clercx, Cécile ULg

in Proceedings of the 55th Annual Conference of the German Small Animal Veterinary Association (2009, November)

Detailed reference viewed: 1 (0 ULg)
Full Text
Peer Reviewed
See detailNasal calcitonin in prevention of early postmenopausal bone loss. A 18-month study
Reginster, Jean-Yves ULg; Franchimont, P

in Journal of Bone and Mineral Research (1988), 3(S1), 163

Detailed reference viewed: 11 (1 ULg)
Full Text
Peer Reviewed
See detailNasal salmon calcitonin for prevention of early postmenopausal bone loss: a dose-ranging placebo controlled study
Reginster, Jean-Yves ULg; DEROISY, Rita ULg; Lecart, MP et al

in Journal of Bone and Mineral Research (1993), 8(S1), 340

Detailed reference viewed: 8 (1 ULg)
Peer Reviewed
See detailNasal salmon calcitonin in prevention of postmenopausal osteoporosis
Reginster, Jean-Yves ULg; DEROISY, Rita ULg; Sarlet, N et al

in Revista Clinica Espanola (1991), 188

Detailed reference viewed: 6 (2 ULg)
Full Text
Peer Reviewed
See detailNash equilibria and reinforcement learning for active decision maker modelling in power markets
Krause, Thilo; Andersson, Goran; Ernst, Damien ULg et al

in Proceedings of the 6th IAEE European Conference: Modelling in Energy Economics and Policy (2004)

In this paper, we study the behavior of power suppliers who submit their bids to the market place in order to maximize their payoffs. The market clearing mechanism is based on the locational marginal ... [more ▼]

In this paper, we study the behavior of power suppliers who submit their bids to the market place in order to maximize their payoffs. The market clearing mechanism is based on the locational marginal price. To study the interaction of the power suppliers, we rely on two different approaches and compare the results obtained. One approach consists of computing the Nash equilibria of the market, and the other models each player’s behavior by using reinforcement learning algorithms. Simulations are carried out on a five node power system. [less ▲]

Detailed reference viewed: 47 (4 ULg)
Full Text
Peer Reviewed
See detailNash equilibrium as the minimum of a function. Application to electricity markets with large number of actors
Beck, Elena Vdovina; Cherkaoui, Rachid; Minoia, Anna et al

in Proceedings of the 2007 Power Tech (2007)

We introduce in this paper a new approach for efficiently identifying Nash equilibria for games composed of large numbers of players having discrete and not too large strategy spaces. The approach is ... [more ▼]

We introduce in this paper a new approach for efficiently identifying Nash equilibria for games composed of large numbers of players having discrete and not too large strategy spaces. The approach is based on a characterization of Nash equilibria in terms of minima of a function and relies on stochastic optimization algorithms to find these minima. The approach is applied to compute Nash equilibria of some electricity markets and, based on the simulation results, its performances are discussed. [less ▲]

Detailed reference viewed: 48 (4 ULg)
Peer Reviewed
See detailNASS Congress
Martin, Didier ULg

Conference (2008, October 14)

Detailed reference viewed: 2 (0 ULg)
Peer Reviewed
See detailNatalizumab induced freedom from disease activity after failure to previous therapy in relapsing remitting multiple sclerosis.
Belachew, Shibeshih ULg; Bartholome E.; DELVAUX, Valérie ULg et al

Conference (2009, June)

Objectives: To analyze the efficacy of natalizumab after switching relapsing-remitting multiple sclerosis (RRMS) patients from other disease modifying treaments (DMTs). Background: Natalizumab (Tysabri ... [more ▼]

Objectives: To analyze the efficacy of natalizumab after switching relapsing-remitting multiple sclerosis (RRMS) patients from other disease modifying treaments (DMTs). Background: Natalizumab (Tysabri) is a monoclonal antibody directed against VLA4 that was recently approved for the treatment of RRMS. Due to safety concerns, the use should be restricted to highly active patients and/or patients with insufficient response to other DMTs. The pivotal trials were not designed to examine the effect of natalizumab as an escalation monotherapy. Methods: Prospective, open label, observational study. All patients initiating natalizumab had experienced at least 1 relapse in the previous year under DMTs and had at least 1 Gd-enhancing lesion on their brain MRI. Previous treatment with interferon-beta (IFN-beta) or glatiramer acetate (GA) were stopped at least one week and azathioprine or mitoxantrone at least 3 months before switching. The minimum therapy duration with natalizumab was 6 months for all patients. 21 RRMS patients were included in this analysis. The mean age of the patients was 25,5 yo with mean disease duration of 6,8 years. All patients were under IFN-beta (17) or GA (4) during at least the previous year before starting natalizumab therapy. Four patients had also received azathioprine and 1 patient mitoxantrone. Results: The mean relapse rate in the previous year was 2.15 (1-4), the mean EDSS at baseline was 3.3 (1,0-6.0), the mean number of Gd+ lesions at baseline 2,58 (1-6). Under tysabri treatment the annualized relapse rate dropped to 0,20. Eleven patients improved their EDSS (0,5 to 1,5 steps down), others remained stable at 6 months. The mean number of Gd+ T1 lesions dropped to 0,23 and the mean number of new T2 lesions was 0.25 on the control MRI at 6 months. 55% of patients were free from disease activity, i.e. had no relapses, no EDSS progression, no new T2 lesion and no Gd+ T1 lesions after 6 months of Tysabri. 5 patients experienced minor adverse events (1 zona, 2 flu-like symptoms, 1 gastroenteritis, 1 allergic reaction). Conclusion: Natalizumab was well tolerated and safe as escalation therapy when previous DMTs had failed to control disease progression in this group of highly active RRMS patients. These results suggest comparable efficacy to the phase III AFFIRM trial of natalizumab when the drug is used in a context of breakthrough disease. Although data from preliminary analyses are promising, long term investigations are warranted. [less ▲]

Detailed reference viewed: 28 (0 ULg)
Full Text
Peer Reviewed
See detailNatalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis.
Belachew, Shibeshih ULg; Phan-Ba, Rémy ULg; Bartholome, Emmanuel et al

in European Journal of Neurology (2010), 18(2), 240-245

Background: Natalizumab (Tysabri) is a monoclonal antibody that was recently approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Our primary objective was to analyse the efficacy ... [more ▼]

Background: Natalizumab (Tysabri) is a monoclonal antibody that was recently approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Our primary objective was to analyse the efficacy of natalizumab on disability status and ambulation after switching patients with RRMS from other disease-modifying treatments (DMTs). Methods: A retrospective, observational study was carried out. All patients (n = 45) initiated natalizumab after experiencing at least 1 relapse in the previous year under interferon-beta (IFNB) or glatiramer acetate (GA) treatments. The patients also had at least 1 gadolinium-enhancing (Gd+) lesion on their baseline brain MRI. Expanded Disability Status Scale (EDSS) scores, and performance on the Timed 25-Foot Walk Test and on the Timed 100-Metre Walk Test were prospectively collected every 4 weeks during 44 weeks of natalizumab treatment. Brain MRI scans were performed after 20 and 44 weeks of treatment. Results: Sixty-two per cent of patients showed no clinical and no radiological signs of disease activity, and 29% showed a rapid and confirmed EDSS improvement over 44 weeks of natalizumab therapy. Patients with improvement on the EDSS showed similar levels of baseline EDSS and active T1 lesions, but had a significantly higher number of relapses, and 92% of them had experienced relapse-mediated sustained EDSS worsening in the previous year. A clinically meaningful improvement in ambulation speed was observed in approximately 30% of patients. Conclusions: These results indicate that natalizumab silences disease activity and rapidly improves disability status and walking performance, possibly through delayed relapse recovery in patients with RRMS who had shown a high level of disease activity under other DMTs. [less ▲]

Detailed reference viewed: 171 (37 ULg)
Full Text
Peer Reviewed
See detailNatalizumab to kill two birds with one stone: A case of celiac disease and multiple sclerosis.
Phan-Ba, Rémy ULg; LAMBINET, Nadine ULg; Louis, Edouard ULg et al

in Inflammatory Bowel Diseases (2011), 17(6), 62-63

Detailed reference viewed: 40 (16 ULg)